SCHEMBL25848204

SCHEMBL25848204

C=CC(=O)OCC(CC)COc1ccc2cc(-c3ccccc3)c(=O)oc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.58
RAB9A P51151 9/20 0.58
KDM4E B2RXH2 3/20 0.56
GLA P06280 3/20 0.56
ALDH1A1 P00352 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
GAA P10253 2/20 0.56
HPGD P15428 2/20 0.56
RECQL P46063 1/20 0.56
HSD17B10 Q99714 1/20 0.56
KLK7 P49862 1/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
RXFP1 Q9HBX9 1/20 0.46
POLB P06746 2/20 0.45
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25848143 0.89 NPC1 (0.60) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL22625383 0.88 NPC1 (0.53) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL22625028 0.87 NPC1 (0.61) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL22624949 0.84 NPC1 (0.55) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL18535437 0.83 THRB (0.44) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL22569369 0.82 NPC1 (0.61) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL25848175 0.81 NPC1 (0.60) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL18571493 0.81 NPC1 (0.53) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL25848234 0.81 NPC1 (0.57) NPC1RAB9AKDM4EGLAALDH1A1
SCHEMBL22624923 0.80 RAB9A (0.42) NPC1RAB9AKDM4EGLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 NPC1 1051/4885RAB9A 1916/4885KDM4E 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.